Millennium Management’s LeMaitre Vascular LMAT Stock Holding History

Millennium Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,000	Closed	-$568K	–	6446
2023 Q4	$568K	Buy	+10,000	New	+$524K	﹤0.01%	4564
2022 Q3	–	Sell	-6,000	Closed	-$273K	–	7317
2022 Q2	$273K	Buy	+6,000	New	+$268K	﹤0.01%	5443
2022 Q1	–	Sell	-20,000	Closed	-$1M	–	7226
2021 Q4	$1M	Hold	20,000	–	–	﹤0.01%	4403
2021 Q3	$1.06M	Hold	20,000	–	–	﹤0.01%	4610
2021 Q2	$1.22M	Hold	20,000	–	–	﹤0.01%	4488
2021 Q1	$976K	Buy	+20,000	New	+$937K	﹤0.01%	4244
2020 Q3	–	Sell	-20,000	Closed	-$528K	–	4662
2020 Q2	$528K	Buy	+20,000	New	+$523K	﹤0.01%	3372
2020 Q1	–	Sell	-30,000	Closed	-$1.08M	–	4211
2019 Q4	$1.08M	Buy	+30,000	New	+$1.04M	﹤0.01%	2969
2019 Q2	–	Sell	-20,000	Closed	-$620K	–	4287
2019 Q1	$620K	Buy	+20,000	New	+$534K	﹤0.01%	3138
2018 Q3	–	Sell	-10,000	Closed	-$335K	–	4114
2018 Q2	$335K	Buy	+10,000	New	+$356K	﹤0.01%	3336

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Millennium Management's LMAT Position: Q2 2026 in Review

Millennium Management reduced its LeMaitre Vascular (LMAT) stake by 83% in Q2 2026, selling an estimated $4.61M and leaving 8,994 shares worth $863K. The position accounts for ﹤0.01% of the portfolio, ranked #4414.

Millennium Management first reported a position in LMAT in Q4 2013 and has held it in 42 quarters since. The position peaked at $24.1M in Q2 2025. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Millennium Management held 8,994 shares of LeMaitre Vascular worth $863K as of Q2 2026.
Millennium Management sold 45,012 LeMaitre Vascular shares in Q2 2026, an estimated $4.61M.
LeMaitre Vascular made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #4414 holding.
Millennium Management first reported a position in LeMaitre Vascular in Q4 2013 and has held it in 42 quarters since.
Millennium Management's LeMaitre Vascular position peaked at $24.1M in Q2 2025.
327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.